Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology - PubMed (original) (raw)
Comparative Study
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Holm H Uhlig et al. Immunity. 2006 Aug.
Free article
Abstract
The CD40-CD154 pathway is important in the pathogenesis of inflammatory bowel disease. Here we show that injection of an agonistic CD40 mAb to T and B cell-deficient mice was sufficient to induce a pathogenic systemic and intestinal innate inflammatory response that was functionally dependent on tumor necrosis factor-alpha and interferon-gamma as well as interleukin-12 p40 and interleukin-23 p40 secretion. CD40-induced colitis, but not wasting disease or serum proinflammatory cytokine production, depended on interleukin-23 p19 secretion, whereas interleukin-12 p35 secretion controlled wasting disease and serum cytokine production but not mucosal immunopathology. Intestinal inflammation was associated with IL-23 (p19) mRNA-producing intestinal dendritic cells and IL-17A mRNA within the intestine. Our experiments identified IL-23 as an effector cytokine within the innate intestinal immune system. The differential role of IL-23 in local but not systemic inflammation suggests that it may make a more specific target for the treatment of IBD.
Comment in
- The many roads to inflammatory bowel diseases.
Neurath MF, Finotto S. Neurath MF, et al. Immunity. 2006 Aug;25(2):189-91. doi: 10.1016/j.immuni.2006.08.005. Immunity. 2006. PMID: 16920636 No abstract available.
Similar articles
- Colonic lamina propria dendritic cells in mice with CD4+ T cell-induced colitis.
Krajina T, Leithäuser F, Möller P, Trobonjaca Z, Reimann J. Krajina T, et al. Eur J Immunol. 2003 Apr;33(4):1073-83. doi: 10.1002/eji.200323518. Eur J Immunol. 2003. PMID: 12672074 - Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis.
Liu Z, Geboes K, Heremans H, Overbergh L, Mathieu C, Rutgeerts P, Ceuppens JL. Liu Z, et al. Eur J Immunol. 2001 May;31(5):1550-60. doi: 10.1002/1521-4141(200105)31:5<1550::AID-IMMU1550>3.0.CO;2-3. Eur J Immunol. 2001. PMID: 11465113 - Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses.
Kelsall BL, Stüber E, Neurath M, Strober W. Kelsall BL, et al. Ann N Y Acad Sci. 1996 Oct 31;795:116-26. doi: 10.1111/j.1749-6632.1996.tb52660.x. Ann N Y Acad Sci. 1996. PMID: 8958922 - Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.
Puccetti P, Belladonna ML, Grohmann U. Puccetti P, et al. Crit Rev Immunol. 2002;22(5-6):373-90. Crit Rev Immunol. 2002. PMID: 12803317 Review. - IL-12 family members in experimental colitis.
Neurath MF. Neurath MF. Mucosal Immunol. 2008 Nov;1 Suppl 1:S28-30. doi: 10.1038/mi.2008.45. Mucosal Immunol. 2008. PMID: 19079224 Review.
Cited by
- CTLA-4 expressing innate lymphoid cells modulate mucosal homeostasis in a microbiota dependent manner.
Lo JW, Schroeder JH, Roberts LB, Mohamed R, Cozzetto D, Beattie G, Omer OS, Ross EM, Heuts F, Jowett GM, Read E, Madgwick M, Neves JF, Korcsmaros T, Jenner RG, Walker LSK, Powell N, Lord GM. Lo JW, et al. Nat Commun. 2024 Nov 4;15(1):9520. doi: 10.1038/s41467-024-51719-6. Nat Commun. 2024. PMID: 39496592 Free PMC article. - Nonclinical evaluations of deucravacitinib and Janus kinase inhibitors in homeostatic and inflammatory pathways.
Johnson B, Cheng L, Koenitzer J, Catlett IM, Schafer P. Johnson B, et al. Front Immunol. 2024 Sep 30;15:1437512. doi: 10.3389/fimmu.2024.1437512. eCollection 2024. Front Immunol. 2024. PMID: 39403378 Free PMC article. - Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells.
Ohara D, Takeuchi Y, Hirota K. Ohara D, et al. Cell Mol Immunol. 2024 Nov;21(11):1183-1200. doi: 10.1038/s41423-024-01218-x. Epub 2024 Oct 8. Cell Mol Immunol. 2024. PMID: 39379604 Free PMC article. Review. - Microbiome- and Host Inflammasome-Targeting Inhibitor Nanoligomers Are Therapeutic in the Murine Colitis Model.
Sharma S, Gilberto VS, Levens CL, Chatterjee A, Kuhn KA, Nagpal P. Sharma S, et al. ACS Pharmacol Transl Sci. 2024 Aug 30;7(9):2677-2693. doi: 10.1021/acsptsci.4c00102. eCollection 2024 Sep 13. ACS Pharmacol Transl Sci. 2024. PMID: 39296260 - JNJ-77242113, a highly potent, selective peptide targeting the IL-23 receptor, provides robust IL-23 pathway inhibition upon oral dosing in rats and humans.
Fourie AM, Cheng X, Chang L, Greving C, Li X, Knight B, Polidori D, Patrick A, Bains T, Steele R, Allen SJ, Patch RJ, Sun C, Somani S, Bhandari A, Liu D, Huie K, Li S, Rodriguez MA, Xue X, Kannan A, Kosoglou T, Sherlock JP, Towne J, Holland MC, Modi NB. Fourie AM, et al. Sci Rep. 2024 Jul 30;14(1):17515. doi: 10.1038/s41598-024-67371-5. Sci Rep. 2024. PMID: 39080319 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials